Inflammaging and osteoarthritis
Osteoarthritis is a highly prevalent disease particularly in subjects over 65 years of age
worldwide. While in the past it was considered a mere consequence of cartilage degradation …
worldwide. While in the past it was considered a mere consequence of cartilage degradation …
[PDF][PDF] The genesis of pain in osteoarthritis: inflammation as a mediator of osteoarthritis pain
Chronic pain is a substantial personal and societal burden worldwide. Osteoarthritis (OA) is
one of the leading causes of chronic pain and is increasing in prevalence in accordance …
one of the leading causes of chronic pain and is increasing in prevalence in accordance …
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
CD Verrico, S Wesson, V Konduri, CJ Hofferek… - Pain, 2020 - journals.lww.com
1. Background Arthritis is a leading cause of pain, disfigurement, and disability in the United
States where nearly one-quarter of all adults have received an affirmative diagnosis. 2 …
States where nearly one-quarter of all adults have received an affirmative diagnosis. 2 …
Monocytes, macrophages, and their potential niches in synovial joints–therapeutic targets in post-traumatic osteoarthritis?
Synovial joints are complex structures that enable normal locomotion. Following injury, they
undergo a series of changes, including a prevalent inflammatory response. This increases …
undergo a series of changes, including a prevalent inflammatory response. This increases …
[HTML][HTML] Recent advances in understanding the phenotypes of osteoarthritis
Recent research in the field of osteoarthritis (OA) has focused on understanding the
underlying molecular and clinical phenotypes of the disease. This narrative review article …
underlying molecular and clinical phenotypes of the disease. This narrative review article …
The potential role of synovial cells in the progression and treatment of osteoarthritis
Osteoarthritis (OA), the commonest arthritis, is characterized by the progressive destruction
of cartilage, leading to disability. The Current early clinical treatment strategy for OA often …
of cartilage, leading to disability. The Current early clinical treatment strategy for OA often …
Recent developments in natural and synthetic polymeric drug delivery systems used for the treatment of osteoarthritis
Osteoarthritis (OA), is a common musculoskeletal disorder that will progressively increase in
older populations and is expected to be the most dominant cause of disability in the world …
older populations and is expected to be the most dominant cause of disability in the world …
Matrix metalloproteinase 3: a promoting and destabilizing factor in the pathogenesis of disease and cell differentiation
J Wan, G Zhang, X Li, X Qiu, J Ouyang, J Dai… - Frontiers in …, 2021 - frontiersin.org
Cells must alter their expression profiles and morphological characteristics but also reshape
the extracellular matrix (ECM) to fulfill their functions throughout their lifespan. Matrix …
the extracellular matrix (ECM) to fulfill their functions throughout their lifespan. Matrix …
CC chemokines and receptors in osteoarthritis: new insights and potential targets
Y Zhang, D Liu, DTA Vithran, BR Kwabena… - Arthritis Research & …, 2023 - Springer
Osteoarthritis (OA) is a prevalent degenerative disease accompanied by the activation of
innate and adaptive immune systems-associated inflammatory responses. Due to the local …
innate and adaptive immune systems-associated inflammatory responses. Due to the local …
The involvement of neutrophils in the pathophysiology and treatment of osteoarthritis
S Chaney, R Vergara, Z Qiryaqoz, K Suggs, A Akkouch - Biomedicines, 2022 - mdpi.com
Osteoarthritis (OA) is a chronic disability that significantly impairs quality of life. OA is one of
the most prevalent joint pathologies in the world, characterized by joint pain and stiffness …
the most prevalent joint pathologies in the world, characterized by joint pain and stiffness …